OverviewSuggest Edit

Metabomed is a drug discovery company in the field of cancer metabolism. The Company is developing a proprietary target identification platform based on computational biology, genomics and metabolomics. The platform identifies metabolic pathways that arise uniquely in cancers that enable and support their growth. These discoveries are used to develop small molecules that specifically target the reprogrammed cancer cells’ metabolism to halt their growth

HQYavne, IL

Latest Updates

Employees (est.) (Nov 2021)19
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Metabomed

Ali Fattaey

Ali Fattaey

Andreas Goutopoulos

Andreas Goutopoulos

Chief Scientific Officer
Aviv Sagi

Aviv Sagi

Omri Erez

Omri Erez

Vice President, Biology
Philippe Nakache

Philippe Nakache

Vice President, Chemistry
David Aviezer

David Aviezer

Chairman of the Board
Show more

Metabomed Office Locations

Metabomed has offices in Yavne and Cambridge
Yavne, IL (HQ)
HaKishon St 18
Cambridge, MA, US
1 Broadway
Show all (2)

Metabomed Financials and Metrics

Summary Metrics

Metabomed total Funding

$18 m

Metabomed latest funding size

$18 m

Time since last funding

6 years ago

Metabomed investors

Metabomed's latest funding round in April 2016 was reported to be $18 m. In total, Metabomed has raised $18 m
Show all financial metrics

Metabomed Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Metabomed Online and Social Media Presence

Embed Graph

Metabomed News and Updates

MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer

CAMBRIDGE, Mass. and YAVNE, Israel, Sept. 9, 2020 /PRNewswire/ -- MetaboMed, a biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced the appointment of Ali Fattaey, Ph.D. as its new CEO. Dr. Fattaey brings over 20...

Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies

YAVNE, Israel and CAMBRIDGE, Massachusetts, Dec. 19, 2019 /PRNewswire/ -- Metabomed, a leading cancer metabolism company completed a financing of $12.5 million bringing the total raised to date to $30 million. The company announced that it has declared a clinical candidate for its...

Metabomed Frequently Asked Questions

  • Who are Metabomed key executives?

    Metabomed's key executives are Ali Fattaey, Andreas Goutopoulos and Aviv Sagi.

  • How many employees does Metabomed have?

    Metabomed has 19 employees.

  • Who are Metabomed competitors?

    Competitors of Metabomed include Galecto, Procarta Biosystems and Exo Therapeutics.

  • Where is Metabomed headquarters?

    Metabomed headquarters is located at HaKishon St 18, Yavne.

  • Where are Metabomed offices?

    Metabomed has offices in Yavne and Cambridge.

  • How many offices does Metabomed have?

    Metabomed has 2 offices.